Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis

Overview of attention for article published in PharmacoEconomics, December 2012

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

policy: 1 policy source

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 70 Mendeley

Summary Policy documents Facebook Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Sarilumab for moderate to severe rheumatoid arthritis: Committee papers

Cited by National Institute for Health and Care Excellence on 14 Sep 2017

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.